common.study.topics.clinical

Liver Biomarkers in Bariatic Surgery

common.study.values.description

Evaluation of Biomarkers to Quantify Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis at Baseline and Following Bariatric Surgery

The purpose of this study is to evaluate imaging and other biomarkers of non-alcoholic fatty liver disease before and after bariatric surgery.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Procedure - Bariatric surgery

Subjects enrolling in the study who are undergoing bariatric surgery as part of their medical care will be studied

Device - HepQuant SHUNT Dual Cholate Liver Diagnostic Kit

For the experimental group, the device will be used to monitor the effect of bariatric surgery on liver function. For the active comparator group, the device will be used for the assessment of baseline liver function.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Evaluation of Biomarkers to Quantify Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis at Baseline and Following Bariatric Surgery

common.study.values.clinical-trial-id

NCT03294850

participant.views.study.view.id

QdJBDd